Literature DB >> 2455228

Variant specific transcripts from the co-transposed segments of variant surface glycoprotein genes in Trypanosoma brucei.

J K Scholler1, R F Aline, K D Stuart.   

Abstract

We examined steady-state transcripts from the sequences immediately upstream of the 1 and 11 variant surface glycoprotein (VSG) genes in Trypanosoma brucei of the IsTaR 1 serodeme. These sequences, the co-transposed segment, differ in size and sequence, and produce a variety of variant-specific polyadenylated transcripts. Most, if not all, of these transcripts, some of which may be precursors, contain the spliced leader (SL). Variant specific transcription extends from 5' of the co-transposed segment to 100-400 nucleotides downstream of the major VSG mRNA polyadenylation site. The 1 VSG mRNA has at least 2, and possibly 3, SL addition sites; the major site is 120 nucleotides downstream of the polyadenylation site identified by sequencing a cDNA from the co-transposed segment. Two general models for the production of the co-transposed segment transcripts are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455228     DOI: 10.1016/0166-6851(88)90123-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  3 in total

1.  Hierarchies of RNA-processing signals in a trypanosome surface antigen mRNA precursor.

Authors:  M Hug; H R Hotz; C Hartmann; C Clayton
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

2.  Expression of a retroposon-like sequence upstream of the putative Trypanosoma brucei variant surface glycoprotein gene expression site promoter.

Authors:  M J Lodes; B L Smiley; A W Stadnyk; J L Bennett; P J Myler; K Stuart
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

3.  Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase does not conform to the 'hotspot' topogenic signal model.

Authors:  G Kendall; A F Wilderspin; F Ashall; M A Miles; J M Kelly
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.